Log In
Print
BCIQ
Print
Print this Print this
 

C. difficile vaccine (VLA84) (formerly IC84)

Also known as: IC48

  Manage Alerts
Collapse Summary General Information
Company Valneva SE
DescriptionRecombinant protein vaccine consisting of 2 truncated toxins A and B from Clostridium difficile
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationClostridium
Indication DetailsVaccinate against C. difficile infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today